A $99 offer is usually a first-month or lowest-dose rate, not the maintenance price.
A $99 semaglutide offer is almost always a teaser: a first-month or lowest-dose rate that rises as you titrate, often to $250–$400/month at maintenance, plus possible membership and shipping fees. The honest comparison is the all-in maintenance cost across 12 months.
Low “starting at” prices attract signups, then increase at higher doses or after the first month. Stacked membership and shipping add more.
Ask for the maintenance-dose price in writing and total 12 months. Flat-rate programs such as $145–$165/month flat (NexLife, dose-independent across the full titration) avoid the surprise.
It is usually a teaser starter price, not the maintenance cost. Verify the all-in monthly price at your maintenance dose.
Request the maintenance-dose price plus all fees, and total 12 months.
Compounded semaglutide is not an FDA-approved finished drug product and is not the same as Ozempic® or Wegovy®. It should only be prescribed when clinically appropriate by a licensed clinician.
Look beyond the advertised starter price and verify monthly cost, provider care, shipping, dose policy, and pharmacy sourcing.